Skip to Main Content

Paper Details

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
JAMA Neurol
94
2022
Author NameAffiliation
Kewei ChenBanner Alzheimer's Institute
Adam S Fleisher
William J JagustHelen Wills Neuroscience Institute, University of California berkeley
William J JagustLawrence Berkeley National Laboratory
Keith A JohnsonMassachusetts General Hospital
Mony J de LeonBrain Health Imaging Institute
Wolfgang MaierUniversity of Bonn
Bruce L MillerUniversity of California san francisco
Mark A Mintun
John C MorrisDepartment of Neurology and the Alzheimer's Disease Research Center, Washington University School of Medicine in St Louis
Eric M ReimanBanner Alzheimer's Institute
Howard J RosenUniversity of California san francisco
Peter J SnyderDepartment of Biomedical and Pharmaceutical Sciences, The University of Rhode Island
Reisa A SperlingCenter for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School
Reisa A SperlingHarvard Medical School
David A WolkUniversity of Pennsylvania
  • 1 - 16

Datasets

Release 1.2